July 28, 2015
Centor is the clear market leader in the US prescription plastic vial retail market for oral drugs The deal extends Gerresheimer’s footprint in the primary...
More July 09, 2015
Revenues up 6.3% to EUR 356.4m (1.9% on an organic basis) Adjusted EBITDA rises 10.6% to EUR 72.1m Net income grows by 7.4% to EUR 22.4m Earnings per share...
More June 30, 2015
Gerresheimer will sell its borosilicate glass tubing business to Corning Corning and Gerresheimer enter into a 10-year-supply agreement for pharmaceutical...
More April 30, 2015
Increase in dividend to EUR 0.75 per share Large majority for resolution approving work of Management Board and Supervisory Board Gerresheimer takes leave of...
More April 30, 2015
Duesseldorf, April 30, 2015 – At its meeting following today’s Annual General Meeting, the Supervisory Board of Gerresheimer AG elected Dr. Axel Herberg (57) as...
More April 14, 2015
Revenues up 1.4% to EUR 301.8m (organic growth -2.4%) Adjusted EBITDA growth of 7.2% to EUR 51.0m (Q1 2014: EUR 47.6m) Net income climbs 22.8% to EUR 12.7m...
More February 11, 2015
Revenues up 1.9% (3.7% organically) to EUR 1,290.0m Adjusted EBITDA totals EUR 258.5m at constant exchange rates Earnings per share up 6.6% to EUR 2.11 ...
More October 22, 2014
Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and healthcare...
More October 08, 2014
Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare Growing importance of drug delivery and dosage devices in Western...
More October 08, 2014
Revenues up 2.2% to EUR 323.9m (+3.2% at constant exchange rates) Adjusted EBITDA with slight improvement on prior-year quarter at EUR 62.1m Net income...
More 